• Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts

    来源: Buzz FX / 13 3月 2025 03:31:17   America/New_York


    Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Shares of Fate Therapeutics, Inc.
    Read more...
分享